All Updates

All Updates

icon
Filter
Partnerships
MiLaboratories partners with Miltenyi Biotec to advance next-generation therapies
Precision Medicine
Apr 29, 2024
This week:
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Funding
OceanWell raises USD 11 million in Series A funding to build water farms
Conservation Tech
Yesterday
Product updates
H launches Runner H, an AI agent for business automation
Foundation Models
Yesterday
Partnerships
Capgemini partners with Mistral AI and Microsoft to expand GenAI solutions globally
Foundation Models
Yesterday
Funding
Product updates
Converge Bio launches biotech LLM platform with USD 5.5 million seed funding
Foundation Models
Yesterday
Partnerships
Snowflake partners with Anthropic to integrate Claude AI models into Cortex AI platform
Foundation Models
Yesterday
Product updates
DeepSeek releases AI reasoning model DeepSeek-R1
Foundation Models
Yesterday
Industry news
Partnerships
ICEYE partners with Lockheed Martin and Finnish firms to develop defense space technologies
Next-gen Satellites
Yesterday
Partnerships
Dematic installs AutoStore system at South West Healthcare logistics hub
Logistics Tech
Yesterday
Precision Medicine

Precision Medicine

Apr 29, 2024

MiLaboratories partners with Miltenyi Biotec to advance next-generation therapies

Partnerships

  • MiLaboratories has teamed up with biotech firm Miltenyi Biotec to combine MiLaboratories' RNA kit technology for immune sequencing with Miltenyi Biotec's production and commercialization capabilities to advance the creation and use of next-generation treatments.

  • MiLaboratories will provide its RNA kits' immune sequencing technology to Miltenyi Biotec as part of this collaboration. Miltenyi Biotec aims to distribute these RNA kits widely, and it is supported by its extensive global reach. Additionally, it will incorporate MiLaboratories’ software solutions, MiXCR and Platforma, into its product offerings to enhance research capabilities and efficiency. The alliance is anticipated to spur innovation and progress in genomics, offering advanced tools to researchers and clinicians globally.

  • MiLaboratories is a biotech company specializing in developing proprietary software designed to map and understand the human immune system at a DNA level. Its flagship product, MiXCR, is a software suite used for the analysis of immunology sequencing data.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.